Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: Sodium Oxybate in Idiopathic Hypersomnia [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial update for sodium oxybate in idiopathic hypersomnia has been completed, reporting results across two trial phases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Oxybate (Sodium Oxybate)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Idiopathic Hypersomnia | Phase 2, Phase 3 | Status: COMPLETED